Yee Chao

13PUBLICATIONS
58CO-AUTHORS
ChemotherapyRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 01, 2025
Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma.

Keun-Wook Lee, Li-Yuan Bai, Minkyu Jung

|Jul 15, 2025
Real-world outcomes of selective internal radiation therapy with <sup>90</sup>Y resin microspheres in HCC/mCRC: RESIN registry Asia.

Chow Wei Too, Po-Chin Liang, Chanisa Chotipanich

|Jan 11, 2024
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion.

Joshua Tobias, Sandra Högler, Martin Raigel

|Nov 11, 2022
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.

I-Cheng Lee, Pei-Chang Lee, Yee Chao

|Oct 14, 2022
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy.

I-Cheng Lee, Keng-Hsin Lan, Chien-Wei Su

|Jul 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai

Pageof 3

Frequent Collaborators

6 joint publications

Yi-Hsiang Huang

3 joint publications

I-Cheng Lee

3 joint publications

Chien-Wei Su

2 joint publications

Kuo-Hung Huang